OpenClinica, the open source clinical trials software has seen a surge in usage over the past year, according to survey data released today by Akaza Research.
“Our recent survey of the OpenClinica community showed strong expansion in all key measurements of system usage,” said Cal Collins, Chief Executive Officer at Akaza. “In the past year we have seen doubling in the number of OpenClinica users and subjects, and a nearly 10-fold increase in regulatory submissions.”